10/15/2024 5:52 AM | Evogene (Subject) SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
09/29/2024 11:15 PM | Evogene (Filer)
| Form EFFECT | |
09/19/2024 3:15 PM | Evogene (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
09/17/2024 6:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024 6:00 AM | Evogene (Filer)
| Form D Notice of Exempt Offering of Securities | |
08/26/2024 8:30 AM | Evogene (Filer)
| Form 424B5 | |
08/23/2024 7:50 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
08/22/2024 6:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024 6:01 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/23/2024 6:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024 6:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024 6:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 10:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 6:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024 6:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024 11:15 PM | Evogene (Filer)
| Form EFFECT | |
03/28/2024 3:45 PM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024 8:16 AM | Evogene (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/20/2024 8:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024 6:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/01/2024 6:03 AM | Evogene (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
02/22/2024 6:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024 6:01 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024 7:30 PM | Evogene (Subject) SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
01/17/2024 6:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024 7:30 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2023 6:00 AM | Evogene (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |